Alignment Healthcare (ALHC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.17
- EPS estimate
- $0.13
- EPS surprise
- +31.78%
- Revenue surprise
- +1.96%
- Revenue
- $1.3B
- Revenue estimate
- $1.3B
- Reported
- Jul 30, 2026
Alignment Healthcare reported Q2 2026 results on July 30, 2026. EPS was $0.17, ahead of the $0.13 estimate by 31.78%. Revenue was about $1.3 billion, matching the consensus as rounded. Compared with Q2 2025, EPS rose from $0.07 and revenue rose from about $1.0 billion.
Alignment lost money in every quarter from Q3 2021 through Q1 2025, and annual losses were $0.82 per share in 2022, $0.79 in 2023 and $0.68 in 2024. The 2025 total was close to breakeven, a loss of $0.01, with profits in Q2 and Q3. The first half of 2026 adds up to $0.22, and Q2 2026 is the highest quarter in the table. Annual revenue grew from $1.43 billion in 2022 to about $3.9 billion in 2025. Alignment beat the EPS estimate in 13 of the last 20 quarters, including each of the last seven.
Alignment reported its third quarter between October 29 and November 4 in each of the past five years. That points to late October or early November 2026 for the Q3 2026 report. It will show whether the run of profitable quarters that began in Q1 2026 continues.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $0.13 | $0.17 | +31.78% | $1.3B | SEC |
| Q1 2026 | Apr 30, 2026 | $0.01 | $0.05 | +604.23% | $1.2B | SEC |
| Q4 2025 | Feb 26, 2026 | −$0.15 | −$0.05 | +67.47% | $1.0B | SEC |
| Q3 2025 | Oct 30, 2025 | −$0.08 | $0.02 | +124.57% | $993.7M | SEC |
| Q2 2025 | Jul 30, 2025 | −$0.07 | $0.07 | +197.63% | $1.0B | SEC |
| Q1 2025 | May 1, 2025 | −$0.13 | −$0.05 | +60.54% | $926.9M | SEC |
| Q4 2024 | Feb 27, 2025 | −$0.19 | −$0.16 | +13.84% | $701.2M | SEC |
| Q3 2024 | Oct 29, 2024 | −$0.11 | −$0.14 | −27.16% | $692.4M | SEC |
| Q2 2024 | Aug 1, 2024 | −$0.12 | −$0.13 | −9.89% | $681.3M | SEC |
| Q1 2024 | May 2, 2024 | −$0.21 | −$0.25 | −20.60% | $628.6M | SEC |
| Q4 2023 | Feb 27, 2024 | −$0.20 | −$0.25 | −26.01% | $465.4M | SEC |
| Q3 2023 | Nov 2, 2023 | −$0.17 | −$0.19 | −13.91% | $456.7M | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.18 | −$0.15 | +18.03% | $462.4M | SEC |
| Q1 2023 | May 4, 2023 | −$0.23 | −$0.20 | +12.51% | $439.2M | SEC |
| Q4 2022 | Feb 28, 2023 | −$0.28 | −$0.31 | −12.20% | $361.8M | SEC |
| Q3 2022 | Nov 3, 2022 | −$0.23 | −$0.22 | +3.38% | $360.3M | — |
| Q2 2022 | Aug 4, 2022 | −$0.22 | −$0.06 | +73.31% | $366.5M | — |
| Q1 2022 | May 5, 2022 | −$0.23 | −$0.23 | +0.17% | $345.5M | — |
| Q4 2021 | Mar 3, 2022 | −$0.28 | −$0.27 | +2.46% | $298.3M | — |
| Q3 2021 | Nov 4, 2021 | −$0.16 | −$0.26 | −58.83% | $293.5M | — |
Quarterly revenue
Frequently asked questions
When did Alignment Healthcare (ALHC) last report earnings?
Alignment Healthcare last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did ALHC beat earnings estimates?
Yes. Alignment Healthcare reported EPS of $0.17 for Q2 2026 against a $0.13 estimate — a 31.78% beat.
How much revenue did ALHC report last quarter?
Alignment Healthcare reported $1.3B in revenue for Q2 2026, against a consensus estimate of $1.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.